ClinicalTrials.govpublic full text
Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
autoimmune diseases of the nervous system, multiple sclerosis, secondary progressive multiple sclerosis, disease progression, brain atrophy, multicenter study, randomized controlled trial, individualized medicine, immunotherapy, myelin proteins, biological agents, interventional
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1046419
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.